<DOC>
	<DOCNO>NCT00336401</DOCNO>
	<brief_summary>Non-cardiac surgery associate significant cardiac morbidity mortality . Volatile anesthetic cardioprotective effect result preservation leave ventricular function lower troponin I level . Lower troponin release correlate good long term event free survival cardiac non cardiac surgery . A recently complete meta-analysis suggest sevoflurane superior volatile agent . The evidence cardioprotective effect non-cardiac surgery lacking . Base current literature , intend evaluate protective potential sevoflurane versus propofol anesthesia high risk patient undergo elective non-cardiac procedure . Hypothesis : The use Sevoflurane general anesthetic reduces postoperative troponin release , incidence myocardial infarction and/or long term morbidity patient low moderate risk postoperative cardiac complication , undergo noncardiac surgery .</brief_summary>
	<brief_title>Peri-Operative And Long-Term Cardioprotective Properties Of Sevoflurane In High Risk Patients Undergoing Non-Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Any patient undergoing noncardiac surgery eligible s/he : 1 . ) ≥45 year old ; 2 . ) Has expect length stay ≥48 hour ; AND3 . ) Fulfills 2 six criterion high cardiac risk define revise Cardiac Risk Index . ( see detail protocol ) 4 . ) Informed consent Exclusion criterion : A patient ineligible study s/he:1 ) Prior adverse reaction sevoflurane ( MH patient ) propofol.2 ) Previous coronary artery bypass graft ( CABG ) surgery complete revascularization precede five year evidence cardiac ischemia since procedure ; or3 ) Has concomitant lifethreatening disease likely limit life expectancy &lt; 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>anesthesia</keyword>
	<keyword>non cardiac surgery</keyword>
	<keyword>cardiac outcome</keyword>
</DOC>